Phase I, First In-human, Double-blind, Randomized, Placebo-controlled Trial to Examine the Safety, Tolerability, and Blood and Plasma Pharmacokinetics of Increasing Single Oral Doses of TMC649128.
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2013
At a glance
- Drugs TMC 649128 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 22 Jun 2011 Status changed from active, no longer recruiting to completed, according to information in a Medivir AB media release.
- 27 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Feb 2011 New trial record